ClariVest Asset Management’s TTEC Holdings TTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9
Closed -$1K 783
2021
Q4
$1K Hold
9
﹤0.01% 731
2021
Q3
$1K Hold
9
﹤0.01% 732
2021
Q2
$1K Hold
9
﹤0.01% 720
2021
Q1
$1K Hold
9
﹤0.01% 711
2020
Q4
$1K Hold
9
﹤0.01% 734
2020
Q3
$0 Hold
9
﹤0.01% 848
2020
Q2
$0 Hold
9
﹤0.01% 850
2020
Q1
$0 Hold
9
﹤0.01% 779
2019
Q4
$0 Hold
9
﹤0.01% 719
2019
Q3
$0 Sell
9
-5,500
-100% -$258K ﹤0.01% 750
2019
Q2
$256K Buy
5,509
+9
+0.2% +$347 0.01% 415
2019
Q1
$199K Sell
5,500
-600
-10% -$20.3K ﹤0.01% 516
2018
Q4
$174K Buy
+6,100
New +$162K ﹤0.01% 547
2016
Q1
Sell
-41,186
Closed -$1.15M 667
2015
Q4
$1.15M Sell
41,186
-954
-2% -$27.3K 0.03% 275
2015
Q3
$1.13M Sell
42,140
-1,000
-2% -$27.3K 0.03% 259
2015
Q2
$1.17M Sell
43,140
-66
-0.2% -$1.72K 0.03% 269
2015
Q1
$1.1M Sell
43,206
-565
-1% -$13.2K 0.03% 278
2014
Q4
$1.04M Sell
43,771
-5,787
-12% -$139K 0.04% 228
2014
Q3
$1.22M Sell
49,558
-39
-0.1% -$1.07K 0.04% 219
2014
Q2
$1.44M Buy
+49,597
New +$1.28M 0.05% 208

Other funds holding TTEC

ClariVest Asset Management's TTEC Position: Q1 2022 in Review

ClariVest Asset Management sold out of TTEC Holdings (TTEC) in Q1 2022, closing a stake of 9 shares — an estimated $1K sold.

ClariVest Asset Management first reported a position in TTEC in Q2 2014 and held it in 20 quarters. The position peaked at $1.44M in Q2 2014. 217 funds tracked by Wall St. Rank hold TTEC as of Q1 2022.

  • ClariVest Asset Management reported no remaining TTEC Holdings position as of Q1 2022 after selling out during the quarter.
  • ClariVest Asset Management sold 9 TTEC Holdings shares in Q1 2022, an estimated $1K.
  • ClariVest Asset Management first reported a position in TTEC Holdings in Q2 2014 and held it in 20 quarters.
  • ClariVest Asset Management's TTEC Holdings position peaked at $1.44M in Q2 2014.
  • 217 funds tracked by Wall St. Rank held TTEC Holdings as of Q1 2022.

Based on ClariVest Asset Management's 13F filing for Q1 2022, filed 4 May 2022.